...
首页> 外文期刊>Journal of Analytical Toxicology >Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography-tandem mass spectrometry.
【24h】

Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography-tandem mass spectrometry.

机译:液相色谱-串联质谱分析法验证口腔液中苯丙胺,鸦片制剂,苯环利定,可卡因和苯甲酰芽子碱的分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present study was to develop and validate a method for the detection and quantitation of drugs of abuse in oral fluids. Fortified oral fluid samples (made in-house) and samples from donors collected with Quantasil oral fluid collection kits from Immunalysis were screened on an Olympus 5400 using reagents purchased from Immunalysis. Amphetamines (AMPs), opiates, phencyclidine (PCP), and cocaine and its metabolite benzoylecgonine (BE) in oral fluids were quantitated by an Applied Biosystems 3200 QTRAP liquid chromatograph-tandem mass spectrometer (LC-MS-MS). AMPs, opiates, PCP, cocaine, and BE were extracted from samples using liquid-liquid or solid-phase extractions and the extracts were separated on a Shimadzu high-performance liquid chromatograph prior to the MS-MS analysis. For each drug, two multiple reaction mode transitions were monitored using positive electrospray ionization coupled to an MS-MS detector. Corresponding d3, d5, d6, and d11 internal standards were used to quantitate the results. The limit of detection/quantitation for AMPs, opiates, PCP, cocaine, and its metabolite BE were 10, 10, 2, 2, and 2 ng/mL of oral fluid, respectively, on a signal-to-noise ratio > 4. This corresponded to 25, 25, 5, 5, and 5 pg on column. The method was verified by participating in the North America Oral Fluid Proficiency Testing administered by Research Triangle Institute and by analyzing real samples from donors. In conclusion, LC-MS-MS provided a simple way to analyze and quantitate drugs of abuse in oral fluids.
机译:本研究的目的是开发和验证一种检测和定量口服液中滥用药物的方法。在Olympus 5400上使用购自Immunalysis的试剂筛选强化的口腔液样品(内部制造)和使用来自Immunlysis的Quantasil口腔液收集试剂盒收集的供体样品。用Applied Biosystems 3200 QTRAP液相色谱-串联质谱仪(LC-MS-MS)对口服液中的苯丙胺(AMPs),鸦片剂,苯环利定(PCP)和可卡因及其代谢产物苯甲酰芽子碱(BE)进行定量。使用液-液相或固相萃取从样品中萃取出AMPs,鸦片制剂,PCP,可卡因和BE,然后在MS-MS分析之前在Shimadzu高效液相色谱仪上对萃取物进行分离。对于每种药物,使用耦合到MS-MS检测器的正电喷雾电离监测两个多重反应模式的转变。相应的d3,d5,d6和d11内标物用于定量结果。当信噪比> 4时,AMPs,鸦片制剂,PCP,可卡因及其代谢产物BE的检测/定量限分别为10、10、2、2和2 ng / mL口服液。这对应于柱上的25、25、5、5和5pg。该方法通过参加由Research Triangle Institute进行的北美口服液水平测试并通过分析来自捐赠者的真实样品而得到验证。总之,LC-MS-MS提供了一种简单的方法来分析和定量口服液中的滥用药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号